VR Logo

Pan Drugs Ltd. download report


Healthcare | Drugs & Pharma

Pan Drugs Ltd. Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2013 Pan Drugs Ltd. Annual Report
2012 Pan Drugs Ltd. Annual Report Pan Drugs Ltd. chairman speech Pan Drugs Ltd. director's report Pan Drugs Ltd. management discussion Pan Drugs Ltd. corporate governance Pan Drugs Ltd. auditor's report Pan Drugs Ltd. account notes
2011 Pan Drugs Ltd. Annual Report Pan Drugs Ltd. chairman speech Pan Drugs Ltd. director's report Pan Drugs Ltd. management discussion Pan Drugs Ltd. corporate governance Pan Drugs Ltd. auditor's report Pan Drugs Ltd. account notes
2010 Pan Drugs Ltd. Annual Report Pan Drugs Ltd. chairman speech Pan Drugs Ltd. director's report Pan Drugs Ltd. management discussion Pan Drugs Ltd. corporate governance Pan Drugs Ltd. auditor's report Pan Drugs Ltd. account notes
1999 Pan Drugs Ltd. Annual Report Pan Drugs Ltd. chairman speech Pan Drugs Ltd. director's report Pan Drugs Ltd. management discussion Pan Drugs Ltd. corporate governance Pan Drugs Ltd. auditor's report Pan Drugs Ltd. account notes
1998 Pan Drugs Ltd. Annual Report Pan Drugs Ltd. chairman speech Pan Drugs Ltd. director's report Pan Drugs Ltd. management discussion Pan Drugs Ltd. corporate governance Pan Drugs Ltd. auditor's report Pan Drugs Ltd. account notes

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1993

Chairman: --

Managing Director: Kamal Natvarlal Pandya

Listing: BSE: 531440

Country: India

Headquarters: Vadodara, Gujarat

Website: -

Key Facts

Market cap: ₹0.64 Cr

Revenue (TTM): 25.09 Cr

Earnings (TTM): 0.28 Cr

Cash: 2.47 Cr

Total Debt: 19.18 Cr

Promoters' ownership: 39.36%

Liquidity:

52 Week range: ₹-- - --

Face value: 10.00

Shares outstanding: 31,43,400

Stock Performance

Time Period S&P BSE Sensex S&P BSE Healthcare
YTD-8.74-17.10--
1 month-2.01-2.03--
3 months-7.32-10.73--
1 Year0.45-13.45--
3 Years10.3219.07--
5 Years11.299.15--
10 Years12.1412.44--
As on 27-Jun-2022